Sarah covers how industries like food and tobacco affect Americans’ bodies and minds. Her interests include ultra-processed foods; smoke-free tobacco; and wellness trends like perimenopause products ...

Compounded Ozempic, Zepbound Still Widely Available Despite End Of Drug Shortages By Dennis Thompson HealthDay ReporterTUESDAY, July 21, 2026 (HealthDay News) — Americans are still buying compounded ...

Please provide your email address to receive an email when new articles are posted on . In a secret shopper study, researchers spoke with 75 businesses selling compounded obesity drugs from August to ...

One simple formula can help you estimate investment growth, understand compounding and measure the impact of inflation.

The truth is much simpler. Compound interest is one of the easiest concepts to understand once someone explains it clearly. More importantly, it is one of the most important ideas in personal finance, ...

Adam Palasciano is a writer over three years of experience writing about personal finance, investing, student loans, and more, for outlets like GOBankingRates, FinanceBuzz, The Penny Hoarder, and Wall ...

Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, infectious disease, telemedicine, mental health and health technology. Emily ...

The Food and Drug Administration on Thursday proposed excluding Novo Nordisk and Eli Lilly’s ‌weight-loss drugs from a key compounding list, potentially limiting large-scale production by outsourcing ...

Learn about compound interest. We will look at how to determine the final value, initial value, interest rate and years needed. We will investigate problems compounded continuously, daily, weekly, ...

While another interest rate pause from the Federal Reserve may not have been the news American borrowers were hoping for this week, it may have led savers to contemplate their next moves. After all, ...

Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The Independent, and Investors Chronicle. VioletaStoimenova / Getty Images ...

Though it’s hard to say exactly what the future holds for mass GLP-1 compounding, the pressure is mounting from multiple angles in the U.S. as drugmakers and the FDA alike seek to crack down on the ...